CIK 0002036042 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sionna Therapeutics, Inc.
Sign in to watch- Ticker
- SION
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-819-2020
- Business address
- 21 HICKORY DRIVE, SUITE 500, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,835,018
- in 1 filing
Net −$21,835,018. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-14 | Booth Bruce Director | Sale 10b5-1 | −105 | $29.95 | $3K | 771,762 |
| 2025-10-13 | Booth Bruce Director | Sale 10b5-1 | −44,048 | $30.32 | $1.3M | 2,719,526 |
| 2025-10-13 | Booth Bruce Director | Sale 10b5-1 | −9,245 | $30.32 | $280K | 772,724 |
| 2025-10-13 | Booth Bruce Director | Sale 10b5-1 | −4,082 | $31.03 | $127K | 2,715,444 |
| 2025-10-13 | Booth Bruce Director | Sale 10b5-1 | −857 | $31.03 | $27K | 771,867 |
| 2025-10-10 | Booth Bruce Director | Sale 10b5-1 | −16,727 | $29.98 | $501K | 2,763,574 |
| 2025-10-10 | Booth Bruce Director | Sale 10b5-1 | −3,511 | $29.98 | $105K | 781,969 |
| 2025-10-06 | Booth Bruce Director | Sale 10b5-1 | −9,753 | $29.95 | $292K | 2,780,301 |
| 2025-10-06 | Booth Bruce Director | Sale 10b5-1 | −2,047 | $29.95 | $61K | 785,480 |
| 2025-10-03 | Booth Bruce Director | Sale 10b5-1 | −31,198 | $30.00 | $936K | 2,790,054 |
| 2025-10-03 | Booth Bruce Director | Sale 10b5-1 | −6,548 | $30.00 | $196K | 787,527 |
| 2025-10-01 | Beer Caroline Stark Chief Business Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +255,000 | 255,000 | ||
| 2025-10-01 | Booth Bruce Director | Sale 10b5-1 | −165 | $29.95 | $5K | 2,821,252 |
| 2025-10-01 | Booth Bruce Director | Sale 10b5-1 | −35 | $29.95 | $1K | 794,075 |
| 2025-09-30 | Booth Bruce Director | Sale 10b5-1 | −10,239 | $30.06 | $308K | 2,821,417 |
| 2025-09-30 | Booth Bruce Director | Sale 10b5-1 | −2,149 | $30.06 | $65K | 794,110 |
| 2025-09-29 | Booth Bruce Director | Sale 10b5-1 | −54,637 | $30.09 | $1.6M | 2,831,656 |
| 2025-09-29 | Booth Bruce Director | Sale 10b5-1 | −11,468 | $30.09 | $345K | 796,259 |
| 2025-09-29 | Cloonan Michael President & CEO | Option exercise 10b5-1 | +7,793 | $6.11 | $48K | 555,136 |
| 2025-09-29 | Cloonan Michael President & CEO | Sale 10b5-1 | −7,793 | $29.70 | $231K | 547,343 |
Page 10 of 15 · 284 trades